InMed Pharmaceuticals (INM) Property, Plant & Equipment (Net) (2020 - 2026)
InMed Pharmaceuticals (INM) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | 2.55 Bn |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 3.93 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 3.76 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 13.44 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 1.93 Bn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 2.44 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 90.50 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 1.41 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 2.96 Bn |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - | 642,884.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 642,884.00 |
| Mar 31, 2026 | 642,884.00 |
| Dec 31, 2025 | 764,254.00 |
| Dec 31, 2025 | 764,254.00 |
| Sep 30, 2025 | 881,549.00 |
| Sep 30, 2025 | 881,549.00 |
| Jun 30, 2025 | 992,199.00 |
| Jun 30, 2025 | 992,199.00 |
| Mar 31, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Dec 31, 2023 | 1.48 Mn |